LONDON, May 30, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Thursday, May 29, 2014, with the NASDAQ Composite closing at 4,247.95, up 0.54%, the Dow Jones Industrial Average ending the session 0.39% higher at 16,698.74, and the S&P 500 edging 0.54% higher to finish the trading session at 1,920.03. The session saw a positive impact from Materials, Consumer Staples and Health Care sectors along with a drag from Telecommunication Services sector. Investor-Edge has initiated coverage on the following equities: Comstock Resources Inc. (NYSE: CRK), Zogenix Inc. (NASDAQ: ZGNX), Mercadolibre Inc. (NASDAQ: MELI) and Clovis Oncology Inc. (NASDAQ: CLVS). Free technical research on CRK, ZGNX, MELI and CLVS can be downloaded upon signing up at:
http://www.investor-edge.com/3209-register
Comstock Resources Inc.'s stock finished Thursday's session 5.87% higher at $27.96. A total of 2.38 million shares were traded, which was above its three months average volume of 1.45 million shares. The stock moved between $26.49 and $28.28 during the session. Over the last three trading sessions and previous three months, Comstock Resources Inc.'s shares have surged 13.38% and 41.50%, respectively. Additionally, from the beginning of 2014, the company's stock has gained an upside of 52.87%. The S&P 500 Energy Sector Index mapped a gain of 0.72% during the trading session and charted up 8.76% in the last three months. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $24.75 is greater than its 200-day moving average of $19.10. Comstock Resources Inc.'s stock has a Relative Strength Index (RSI) of 55.68. Sign up today to read free research on CRK at:
http://www.investor-edge.com/3209-CRK-30May2014.pdf
On Thursday, shares in Zogenix Inc. fluctuated between $2.04 and $2.21 before ending the session 7.43% higher at $2.17. Zogenix Inc.'s stock reported a trading volume of 1.70 million shares, much below its three months average volume of 3.20 million shares. Zogenix Inc.'s shares have declined 15.89% in the last one month and 36.92% on YTD basis. However, the company's stock has gained 5.85% in the previous three trading sessions. The S&P 500 Health Care Sector Index mapped a gain of 0.76% during the trading session and charted up 2.45% in the last one month. The stock is trading below its 50-day and 200-day moving averages of $2.59 and $2.94, respectively. Moreover, shares of the company have an RSI of 34.47. Sign up today to read free research on ZGNX at:
http://www.investor-edge.com/3209-ZGNX-30May2014.pdf
MercadoLibre Inc.'s stock rallied 6.71%, closing the day at $87.61. The stock recorded a trading volume of 2.11 million shares, above its three months average volume of 0.82 million shares. The stock oscillated between $84.42 and $90.51 during the trading session. Although, MercadoLibre Inc.'s shares have gained 4.16% in the previous three trading sessions, it has fallen by 0.33% in the last one month and 18.72% on YTD basis. Shares of the company traded at a PE ratio of 29.51. The S&P 500 Information Technology Sector Index mapped a gain of 0.66% during the trading session and charted up 3.85% in the past three months. The stock is trading below its 50-day and 200-day moving averages. Further, the stock's 200-day moving average of $107.33 is greater than its 50-day moving average of $88.41. Additionally, the stock has an RSI of 40.59. Sign up today to read free research on MELI at:
http://www.investor-edge.com/3209-MELI-30May2014.pdf
On Thursday, shares in Clovis Oncology Inc. recorded a trading volume of 1.14 million shares, higher than its three months average volume of 0.73 million shares. The stock ended the day at $51.55, which was 5.25% above its previous day's closing, and registered an intraday range of $49.14 and $53.28. Clovis Oncology Inc.'s shares have declined 9.56% in the previous three trading sessions, 3.01% in the last one month and 14.47% on YTD basis. The S&P 500 Health Care Sector Index mapped a gain of 0.76% during the trading session and charted up 1.05% in the last three trading sessions. The company's stock is trading below its 50-day and 200-day moving averages of $60.70 and $62.88, respectively. Furthermore, shares of the company have an RSI of 38.41. Sign up today to read free research on CLVS at:
http://www.investor-edge.com/3209-CLVS-30May2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Investor-Edge.com
SOURCE Investor-Edge
